Blood Bank

What if one of Australia’s biggest growth stocks lost more than half its value, while a bank once considered cheap nearly tripled? In our latest video, Dougal Maple-Brown unpacks one of the most striking valuation reversals in recent Australian market history and explains how our valuation-driven approach positioned portfolios to benefit.